Hyperimmune Colostrum and Oral Mucositis
Not Applicable
- Conditions
- Head and Neck Cancer
- Interventions
- Dietary Supplement: hyperimmune colostrumDietary Supplement: Placebo
- Registration Number
- NCT00699569
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Brief Summary
To study the effect of daily intake of hyperimmune colostrum on prevention and treatment of oral mucositis in patients with head and neck cancer undergoing high-dose radiation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Patients with: naso-pharynx, oral cavity, oro-pharynx and advanced localized laryngeal cancer.
Exclusion Criteria
- Other tumors
- Non-epithelial tumors
- Pregnancy
- Poor functional status
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1 hyperimmune colostrum Patients receiving active investigational product 2 Placebo Patients receiving Placebo
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sourasky Medical Center
🇮🇱Tel-Aviv, Israel